Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes

Publication
Kidney Int pii:S0085-2538(19)30841-5. https://doi.org/10.1016/j.kint.2019.07.025